Skip to main content

Dan Roden

Personalized medicine focus of Chancellor’s Lecture

Sep. 6, 2012—The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.

Read more


BioVU reaches new benchmark in DNA samples

Sep. 6, 2012—This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information.

Read more


Director of Vanderbilt’s DNA databank to discuss reality and hype of personalized medicine

Aug. 30, 2012—The director of Vanderbilt’s DNA databank will discuss the possibilities of personalized medicine in the first Chancellor’s Lecture of the academic year.

Read more


Key to a woman’s heart (condition)?

Aug. 10, 2012—Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.

Read more


Next My Health Chat: ‘Your Genome and the Future of Medicine’

Feb. 22, 2012—The March edition of My Health Chat will focus on the broad implications for the future of medicine presented by the sequencing of the human genome. Host Jim Jirjis will be joined March 7 by Gordon Bernard, Vanderbilt University Medical Center’s associate vice chancellor for clinical and translational research, and Dan Roden, assistant vice chancellor...

Read more


Investigators seek clues to paradox of atrial fibrillation risk

Feb. 17, 2012—Vanderbilt researchers are seeking genetic clues to explain why risk factors for AF are more prevalent in African-Americans but their incidence of the disease is lower than European-Americans.

Read more


Dr. Dan Roden: “Personalized Medicine: Your genome and the future of medicine”

Jan. 27, 2012—Watch video of Dr. Dan Roden speaking about personalized medicine. Roden spoke Jan. 25 as part of the Osher Lifelong Learning class, “Medical Advances.” The course is presented by faculty of the Vanderbilt University Medical Center and focuses on what the future of medicine holds. Physicians are now able to use a patient’s DNA to select...

Read more


Study points to personal treatment for atrial fibrillation

Dec. 6, 2011—Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy.

Read more


Project seeks to apply gene testing to drug prescribing

Nov. 11, 2011—The U.S. Centers for Disease Control and Prevention has awarded Vanderbilt researchers a two-year, $1 million grant to Vanderbilt to develop a model for applying genomic testing to drug prescribing in “real-world” settings.

Read more


Vanderbilt doctors to screen patients taking statins for genetic risk factors

Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

Read more


Vanderbilt: Laboratory for health care reform

Apr. 15, 2011—Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science and clinical medicine to the solution of critical problems in patient care. Bedside checklists and electronic “dashboards” developed at Vanderbilt, for example, enable doctors and nurses to chart in exquisite...

Read more


VIEW MORE EVENTS >